Jefferies Keeps Their Buy Rating on Viatris (VTRS)
Jefferies analyst maintained a Buy rating on Viatris today and set a price target of $17.00.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
In addition to Jefferies, Viatris also received a Buy from Truist Financial’s Les Sulewski in a report issued today. However, on the same day, Goldman Sachs maintained a Hold rating on Viatris (NASDAQ: VTRS).
Based on Viatris’ latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $3.7 billion and a GAAP net loss of $340.1 million. In comparison, last year the company earned a revenue of $3.53 billion and had a GAAP net loss of $516.5 million
Based on the recent corporate insider activity of 30 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of VTRS in relation to earlier this year. Earlier this month, David Simmons, a Director at VTRS bought 499.00 shares for a total of $5,199.58.
Read More on VTRS:
Disclaimer & DisclosureReport an Issue
- Viatris outlines vision for growth through 2030
- Viatris-Backed Nyxol Trial Completes Phase 3, Setting Up a Key Night-Vision Catalyst
- Unusually active option classes on open March 12th
- The Week That Was, The Week Ahead: Macro and Markets, Mar. 8
- Viatris Earnings Call Highlights Slow Growth, Cash Strength
